greater trochanteric pain syndrome

From Aaushi
Jump to navigation Jump to search

Introduction

disorders of the lateral, peritrochanteric space of the hip

Etiology

Epidemiology

  • relatively common, affects 10-25% of the general population

Clinical manifestations

Differential diagnosis

Management

* treatment not recognized by ref[5]

More general terms

More specific terms

Additional terms

References

  1. Strauss EJ, Nho SJ, Kelly BT. Greater trochanteric pain syndrome. Sports Med Arthrosc. 2010 Jun;18(2):113-9 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20473130
  2. Jump up to: 2.0 2.1 2.2 Ramon S et al. Focused shockwave treatment for greater trochanteric pain syndrome: A multicenter, randomized, controlled clinical trial. J Bone Joint Surg Am 2020 Aug 5; 102:1305. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32769596
  3. Jump up to: 3.0 3.1 Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
    Medical Knowledge Self Assessment Program (MKSAP) 20 American College of Physicians, Philadelphia 2025
  4. Pianka MA, Serino J, DeFroda SF, et al. Greater trochanteric pain syndrome: Evaluation and management of a wide spectrum of pathology. SAGE Open Med. 2021;9:20503121211022582. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34158938
  5. Jump up to: 5.0 5.1 5.2 5.3 5.4 NEJM Knowledge+
  6. Jump up to: 6.0 6.1 Atchia I et al. Efficacy of platelet-rich plasma versus placebo for the treatment of greater trochanteric pain syndrome: A double-blinded randomized controlled trial. J Bone Joint Surg Am 2025 Mar 5; 107:444. PMID: https://www.ncbi.nlm.nih.gov/pubmed/39804899
  7. Speers CJ, Bhogal GS. Greater trochanteric pain syndrome: a review of diagnosis and management in general practice. Br J Gen Pract. 2017;67:479-480. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28963433